| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |